Aimmune Therapeutics Inc (NASDAQ: AIMT) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: DeDe Sheel -- Vice President of Investor Relations
Aimmune Therapeutics Inc
-(AIMT)
XNAS:AIMT
News . Data . Research
News . Data . Research
XNAS:AIMT
Aimmune Therapeutics Inc (NASDAQ: AIMT) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: DeDe Sheel -- Vice President of Investor Relations